Search - tctmd.com

Displaying 1 - 20 of 129

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

Presenter: Seung-Jun Lee

October 28, 2024

Presentation TCT 2024

TCT 696: Survival Benefit of Optimal Glycemic Control in Diabetic Patients Undergoing Endovascular Therapy for Femoropopliteal Disease

Presenter: Jae Young Jeung

October 28, 2024

Presentation TCT 2024

TCT 691: Endovascular Treatment of Femoropopliteal Peripheral Arterial Disease Lesions With the Novel Sirolimus-Coated Balloons: A Meta-Analysis

Presenter: Hamza Naveed

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

Presentation ACC 2024

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

Presenter: Young-Guk Ko

April 08, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

Presentation TCT 2023

TCT 469: Optical coherence tomography predicts major adverse limb events in patients with femoropopliteal artery disease

Presenter: Donna Lin

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

Presentation TCT 2023

TCT 157: Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety and One-Year Outcomes. An All-Comers Registry.

Presenter: Marco Ferrone

October 24, 2023

Presentation TCT 2023

Percutaneous Transmural Bypass for Long and Complex Femoropopliteal Lesions: Clinical Outcomes of the DETOUR-2 Study

Presenter: Ajanta De

October 24, 2023

News Daily News

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Todd Neale

October 16, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Conference News LINC 2023

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

L.A. McKeown

June 08, 2023

Advertisement

Top Endovascular News of 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

TCT 696: Survival Benefit of Optimal Glycemic Control in Diabetic Patients Undergoing Endovascular Therapy for Femoropopliteal Disease

TCT 691: Endovascular Treatment of Femoropopliteal Peripheral Arterial Disease Lesions With the Novel Sirolimus-Coated Balloons: A Meta-Analysis

What’s Going to Be Big at TCT 2024?

Scientific Statement Reviews Current Antithrombotic Options in PAD

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

TCT 469: Optical coherence tomography predicts major adverse limb events in patients with femoropopliteal artery disease

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

TCT 157: Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety and One-Year Outcomes. An All-Comers Registry.

Percutaneous Transmural Bypass for Long and Complex Femoropopliteal Lesions: Clinical Outcomes of the DETOUR-2 Study

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

FDA Approves DETOUR for Percutaneous Bypass in Long, Complex SFA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content